Back to search
FDAFDA · Food and drugs·Recall number D-0600-2021

Micardis Tablets, (telmisartan Tablets) 80 mg, 30 ct. per folding cartons, Rx only, NDC 0597-0041-37), Distributed by: Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT 06877

Published June 9, 2021 · Recall initiated: May 4, 2021

Summary

FDA records drug Class II recall D-0600-2021, published June 9, 2021 and initiated May 4, 2021. Recalling firm: Boehringer Ingelheim Pharmaceuticals, Inc.; Status: Terminated; Reported quantity: 15,198 bottles (30 tablets per bottle); Lot: Lot #860412; SEPT 2022. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Subpotent Drug

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Boehringer Ingelheim Pharmaceuticals, Inc.
Distributor
AR, CO, CT, LA, NC, ND, NH, NJ, OH, PA and PR
Lot
Lot #860412; SEPT 2022
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Micardis Tablets, (telmisartan Tablets) 80 mg, 30 ct. per folding cartons, Rx only, NDC 0597-0041-37), Distributed by: Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT 06877 recalled?

Yes. FDA published recall D-0600-2021 on June 9, 2021. Reported hazard: Subpotent Drug

What should I do if I have this product?

Voluntary: Firm initiated · Letter